Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Primary Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07700238
What this trial is testing

Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Amgen 126
Not applicableStudy completedNCT06071520
What this trial is testing

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 50
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Large-scale testing (Phase 3)Looking for participantsNCT07233213
What this trial is testing

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableUnknownNCT04949009
What this trial is testing

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Study completedNCT01667263
What this trial is testing

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Peking University People's Hospital 130
Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Early research (Phase 1)Looking for participantsNCT07206758
What this trial is testing

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd 10
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableStudy completedNCT03576742
What this trial is testing

Severe Immune Cytopenia Registry Www.Sic-reg.Org

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome+1 more
Medical University of Graz 80
Not applicableUnknownNCT05468866
What this trial is testing

The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Sohag University 100
Not applicableUnknownNCT02967328
What this trial is testing

RP% Measurement by FCM as a Diagnostic Test for ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 500
Large-scale testing (Phase 3)UnknownNCT03692754
What this trial is testing

Atorvastatin in Management of Newly Diagnosed ITP

Who this might be right for
Immune ThrombocytopeniaPurpura, Thrombocytopenic
Shandong University 30
Very early researchStudy completedNCT05551624
What this trial is testing

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Who this might be right for
Primary Immune Thrombocytopenia
Hospital Civil de Guadalajara 15
Testing effectiveness (Phase 2)Looking for participantsNCT07065968
What this trial is testing

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 132
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Next Page